Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.51 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL218978 | 0.92 | DRD2 (0.45) | CARM1PRMT6DRD2DRD4CHRNB2 | |
| SCHEMBL2456728 | 0.90 | DRD2 (0.44) | CARM1PRMT6DRD2DRD4CHRNB2 | |
| SCHEMBL218458 | 0.90 | JMJD6 (0.45) | CARM1PRMT6DRD2DRD4CHRNB2 | |
| SCHEMBL25277718 | 0.88 | NR1H4 (0.43) | CARM1PRMT6DRD2DRD4CHRNB2 | |
| SCHEMBL532785 | 0.87 | CARM1 (0.61) | CARM1PRMT6DRD2DRD4CHRNB2 | |
| SCHEMBL8447322 | 0.87 | CARM1 (0.61) | CARM1PRMT6DRD2DRD4CHRNB2 | |
| SCHEMBL14397614 | 0.87 | CARM1 (0.52) | CARM1PRMT6DRD2DRD4CHRNB2 | |
| SCHEMBL28356623 | 0.86 | MEN1 (0.49) | CARM1PRMT6CHRNA7TDP1KMT2A | |
| SCHEMBL16425299 | 0.85 | CARM1 (0.51) | CARM1PRMT6DRD2DRD4CHRNB2 | |
| SCHEMBL14458250 | 0.83 | CARM1 (0.58) | CARM1PRMT6DRD2DRD4CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9212244-B2 | Polymers made from mixtures comprising vinyl ether monomers | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2015-12-15 | — | — | US | claimed |
| US-20100242790-A1 | CATIONICALLY AND HYBRID CURABLE UV GELS | XEROX CORPORATION (US) | 2010-09-30 | — | — | US | claimed |
| EP-2233541-A1 | Cationically and hybrid curable UV gels | Xerox Corporation (US) | 2010-09-29 | — | — | EP | claimed |
| EP-4565378-B1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-05-06 | — | — | EP | disclosed |
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | SICPA HOLDING SA (CH) | 2026-05-05 | — | — | US | disclosed |
| EP-4352175-B1 | HYBRID UV-LED RADIATION CURABLE PROTECTIVE VARNISHES FOR SECURITY DOCUMENTS | SICPA HOLDING SA (CH) | 2026-02-25 | — | — | EP | disclosed |
| US-12535735-B2 | Modified thioxanthone photoinitiators | LINTFIELD LIMITED (GB) | 2026-01-27 | — | — | US | disclosed |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-01-15 | — | — | US | disclosed |
| US-12515470-B2 | UV-Vis radiation curable security inks | SICPA HOLDING SA (CH) | 2026-01-06 | — | — | US | disclosed |
| EP-4433547-B1 | METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2025-12-24 | — | — | EP | disclosed |
| US-12398152-B2 | Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition | LINTFIELD LIMITED (GB) | 2025-08-26 | — | — | US | disclosed |
| US-6986855-B1 | Structural and optical applications for shape memory polymers (SMP) | CORNERSTONE RESEARCH GROUP (US) | 2006-01-17 | — | — | US | disclosed |
| EP-1373340-B1 | SHAPE MEMORY POLYMER OR ALLOY OPHTHALMIC LENS MOLD AND METHODS OF FORMING OPHTHALMIC PRODUCTS | JOHNSON & JOHNSON VISION CARE (US) | 2005-10-19 | — | — | EP | disclosed |
| US-6827325-B2 | Shape memory polymer or alloy ophthalmic lens mold and methods of forming ophthalmic products | JOHNSON & JOHNSON VISION CARE, INC. | 2004-12-07 | — | — | US | disclosed |
| US-6759481-B2 | Shape memory styrene copolymer | CORNERSTONE RESEARCH GROUP, INC. | 2004-07-06 | — | — | US | disclosed |
| US-20040015261-A1 | Shape memory polymer or alloy ophthalmic lens mold and methods of forming ophthalmic products | JOHNSON & JOHNSON VISION CARE, INC. | 2004-01-22 | — | — | US | disclosed |
| EP-1373340-A1 | SHAPE MEMORY POLYMER OR ALLOY OPHTHALMIC LENS MOLD AND METHODS OF FORMING OPHTHALMIC PRODUCTS | Johnson & Johnson Vision Care, Inc. (US) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002059169-A9 | SHAPE MEMORY POLYMER OR ALLOY OPHTHALMIC LENS MOLD AND METHODS OF FORMING OPHTHALMIC PRODUCTS | JOHNSON & JOHNSON VISION CARE (US) | 2003-01-09 | — | — | WO | disclosed |
| US-20020137864-A1 | Shape memory styrene copolymer | CORNERSTONE RESEARCH GROUP, INC. | 2002-09-26 | — | — | US | disclosed |
| WO-2002059169-A1 | SHAPE MEMORY POLYMER OR ALLOY OPHTHALMIC LENS MOLD AND METHODS OF FORMING OPHTHALMIC PRODUCTS | JOHNSON & JOHNSON VISION CARE , INC. (US) | 2002-08-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12398152-B2 | Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition | TPMT, TST, PPOX | CARM1 3492/4885PRMT6 3256/4885DRD2 2166/4885 |
| US-12535735-B2 | Modified thioxanthone photoinitiators | FTO, UGT1A6, TPMT | CARM1 901/4885PRMT6 688/4885DRD2 1887/4885 |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | IK, TEX10, INCENP | CARM1 2314/4885PRMT6 2432/4885DRD2 3442/4885 |
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | ATG4B, TPM4, ATG4A | CARM1 3150/4885PRMT6 3636/4885DRD2 1817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.